| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.1 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.1 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.1 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.045 | 0.1 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |